HIGHLIGHTS
- who: Michael Marks and colleagues from the Faculty University of Melbourne, Melbourne, Australia have published the research: M A J O R A R T I C L E Clinical Infectious Diseases, in the Journal: (JOURNAL)
- what: The authors demonstrate the sustained impact of a single round of ivermectin-based MDA on the prevalence of scabies and impetigo for 3 years after intervention. In the study , reported coverage was very high, above 95% for the first dose and above 80% for the second dose of treatment.
- how: In 2015 the authors conducted a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.